J
Juan Ambrosioni
Researcher at University of Barcelona
Publications - 149
Citations - 3726
Juan Ambrosioni is an academic researcher from University of Barcelona. The author has contributed to research in topics: Medicine & Viral load. The author has an hindex of 23, co-authored 115 publications receiving 2436 citations. Previous affiliations of Juan Ambrosioni include Geneva College & University of Geneva.
Papers
More filters
Journal ArticleDOI
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
Carolina Garcia-Vidal,Gemma Sanjuan,Estela Moreno-García,Pedro Puerta-Alcalde,Nicole Garcia-Pouton,Mariana Chumbita,Mariana J. Fernandez-Pittol,Cristina Pitart,Alexy Inciarte,Marta Bodro,Laura Morata,Juan Ambrosioni,Ignacio Grafia,Fernanda Meira,Irene Macaya,Celia Cardozo,Climent Casals,Adrián Téllez,Pedro Castro,Francesc Marco,Felipe García,Josep Mensa,José Antonio Martínez,Alex Soriano,Verónica Rico,Marta Hernández-Meneses,Daiana Agüero,Berta Torres,Ana González,Lorena de la Mora,Jhon Rojas,Laura Linares,Berta Fidalgo,Natalia Rodríguez,David Nicolás,Laia Albiach,Jose Muñoz,Alex Almuedo,Daniel Camprubí,M. A. Marcos,Catia Cilloniz,Sara Fernández,Jose María Nicolás,Antoni Torres +43 more
TL;DR: The burden, epidemiology and outcomes of co-infections and superinfections occurring in hospitalized patients with coronavirus disease 2019 (COVID-19) could prove essential in defining the role of empiric antimicrobial therapy or stewardship strategies.
Journal ArticleDOI
COVID-19 in patients with HIV: clinical case series.
José Luis Santiago Blanco,Juan Ambrosioni,Felipe García,Esteban Martínez,Alex Soriano,Josep Mallolas,José M. Miró +6 more
TL;DR: The first single-centre experience of COVID-19 in patients infected with HIV-1 is described, to the authors' knowledge, including clinical characteristics, antiviral and antiretroviral treatment, and outcomes.
Journal ArticleDOI
Nocardiosis: Updated Clinical Review and Experience at a Tertiary Center
TL;DR: Although sulfonamides in combination with other antibiotics are still the treatment of choice, other associations such as imipenem plus amikacin are preferred in some centers and Linezolid is a useful alternative therapeutic agent due to its oral availability and activity against most of the isolate studied.
Journal ArticleDOI
Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.
Lene Ryom,Christoph Boesecke,M Bracchi,Juan Ambrosioni,Anton Pozniak,Jose R. Arribas,Georg M. N. Behrens,Pgm Mallon,Massimo Puoti,Andri Rauch,Miró Jm,Ole Kirk,Catia Marzolini,Catia Marzolini,Jens D Lundgren,Manuel Battegay +15 more
TL;DR: The European AIDS Clinical Society (EACS) Guidelines have since 2005 provided multidisciplinary recommendations for the care of HIV‐positive persons in geographically diverse areas.
Journal ArticleDOI
Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007
TL;DR: ChD reactivation should be considered as a differential diagnosis of meningoencephalitis in HIV patients with low CD4 T-cell counts, previous residency in an endemic area, and/or IDUs.